NCT04141956View on ClinicalTrials.gov

Incidence of Use of High-Flow Nasal Cannula Oxygen Therapy in Intensive Care Units Patients

CompletedOBSERVATIONAL
Enrollment

257

Participants

Timeline

Start Date

November 2, 2019

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Oxygen Deficiency
Interventions
OTHER

High-Flow Nasal Cannula

Incidence of nasal High Flow Nasal Cannula (HFNC) Oxygen therapy in patients admitted to intensive care.

Trial Locations (10)

14033

CHU CAEN, Caen

25030

Chu Jean Minjoz Besancon, Besançon

37044

Chru Bretonneau - Tours, Tours

44606

CH de SAINT NAZAIRE, Saint-Nazaire

45067

Chru Orleans, Orléans

50100

Polyclinique Du Cotentin, Cherbourg

56017

Centre Hospitalier Bretagne-Atlantique -Site de Vannes, Vannes

72037

Centre Hospitalier Du Mans, Le Mans

92150

Hopital Foch, Suresnes

Unknown

CHU de Nantes, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT04141956 - Incidence of Use of High-Flow Nasal Cannula Oxygen Therapy in Intensive Care Units Patients | Biotech Hunter | Biotech Hunter